folic acid has been researched along with Angiogenesis, Pathologic in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 9 (56.25) | 24.3611 |
| 2020's | 4 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, L; Pan, D; Sun, G; Wang, S; Wei, J; Xia, H; Xu, Y | 1 |
| Cui, H; Liu, X | 1 |
| Chen, J; Chen, X; Ge, Y; Huang, K; Lin, Z; Lv, Z; Pan, Y; Sun, X; Yao, Q; Yu, H | 1 |
| Böhm, J; Bours, MJL; Brezina, S; Geijsen, AJMR; Gigic, B; Gsur, A; Gumpenberger, T; Habermann, N; Hardikar, S; Himbert, C; Holowatyj, AN; Kiblawi, R; Kok, DE; Koole, JL; Lin, T; Ose, J; Playdon, M; Schneider, M; Schrotz-King, P; Ueland, PM; Ulrich, A; Ulrich, CM; Ulvik, A; van Duijnhoven, FJB; van Roekel, EH; Warby, CA; Weijenberg, MP | 1 |
| Xu, L; Yang, H; Yeudall, WA | 1 |
| Lei, XW; Li, Q; Liu, Y; Yang, KH; Zhang, JZ; Zhang, YM | 1 |
| Chen, H; Li, J; Li, X; Luo, J; Niu, W; Tang, J; Tong, L; Wang, J; Wang, Y; Xiao, Q; Zhong, L; Zhu, J | 1 |
| Beland, FA; Campos, A; Carrilho, J; de Conti, A; Furtado, KS; Fuscoe, JC; Guariento, AH; Han, T; Moreno, FS; Pogribny, IP; Purgatto, E; Ross, SA; Shinohara, EM; Tryndyak, V | 1 |
| Chen, KC; Ding, CY; Hsieh, CL; Peng, CC; Tsai, WJ; Wu, JF | 1 |
| Hattori, Y; Kawano, K; Sakaida, C; Yamashita, J; Yonemochi, E | 1 |
| Al-Wahab, Z; Chhina, J; Dar, S; Das, S; Giri, S; Gupta, A; Hijaz, M; Mert, I; Munkarah, A; Rattan, R; Seal, S; Tebbe, C | 1 |
| Bandara, NA; Bates, CD; Hoylman, EK; Low, PS; Lu, Y | 1 |
| Gazzola, A; Piccaluga, PP; Pileri, SA; Roncolato, F; Zinzani, PL | 1 |
| Akita, T; Duan, J; Egami, K; Ikeda, H; Imaizumi, T; Murohara, T; Sasaki, K; Shimada, T; Shintani, S | 1 |
| Labhasetwar, V; Vasir, JK | 1 |
| Atta, HM; El-Rehani, MA; Galal, AM; Raheim, SA | 1 |
2 review(s) available for folic acid and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Targeted molecular therapy in peripheral T-cell lymphomas.
Topics: Folic Acid; Histone Deacetylases; Humans; Lymphoma, T-Cell, Peripheral; Molecular Targeted Therapy; Neovascularization, Pathologic; NF-kappa B; Receptor, Platelet-Derived Growth Factor alpha; Receptors, Cell Surface; TOR Serine-Threonine Kinases; Tumor Microenvironment | 2011 |
Targeted drug delivery in cancer therapy.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Carrier Proteins; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Drug Resistance, Multiple; Endothelium, Vascular; Folate Receptors, GPI-Anchored; Folic Acid; Gene Transfer Techniques; Humans; Immunotherapy; Immunotoxins; Ligands; Magnetics; Mice; Nanostructures; Neoplasms; Neovascularization, Pathologic; Oleic Acid; Receptors, Cell Surface; Receptors, LDL; Recombinant Fusion Proteins; Time Factors; Trastuzumab | 2005 |
14 other study(ies) available for folic acid and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Folic Acid Inhibited Vasculogenic Mimicry in Esophageal Cancer Cell Line Eca-109, the One Target Was EphA2.
Topics: Cell Line, Tumor; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Folic Acid; Humans; Neovascularization, Pathologic | 2022 |
The palliative effects of folic acid on retinal microvessels in diabetic retinopathy via regulating the metabolism of DNA methylation and hydroxymethylation.
Topics: Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Retinopathy; DNA (Cytosine-5-)-Methyltransferase 1; DNA Methylation; Endothelial Cells; Folic Acid; Humans; Male; Microvessels; Neovascularization, Pathologic; Promoter Regions, Genetic; Rats; Rats, Sprague-Dawley; Retina; Transcriptome; Zinc Fingers | 2021 |
Immunomodulation of MiRNA-223-based nanoplatform for targeted therapy in retinopathy of prematurity.
Topics: Animals; Chitosan; Disease Models, Animal; Folic Acid; Humans; Immunomodulation; Infant, Newborn; Inflammation; Interleukin-6; Mice; MicroRNAs; Neovascularization, Pathologic; Oxygen; Retinopathy of Prematurity; Silicon Dioxide | 2022 |
One-carbon metabolites, B vitamins and associations with systemic inflammation and angiogenesis biomarkers among colorectal cancer patients: results from the ColoCare Study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amyloid; Biomarkers, Tumor; C-Reactive Protein; Carbon; Colorectal Neoplasms; Cross-Sectional Studies; Female; Folic Acid; Glutamates; Humans; Inflammation; Inflammation Mediators; Interleukin-6; Interleukin-8; Intestines; Linear Models; Male; Middle Aged; Neovascularization, Pathologic; Phosphoric Monoester Hydrolases; Prospective Studies; Statistics, Nonparametric; Tetrahydrofolates; Tumor Necrosis Factor-alpha; Vitamin B Complex; Young Adult | 2020 |
Folic acid-decorated polyamidoamine dendrimer exhibits high tumor uptake and sustained highly localized retention in solid tumors: Its utility for local siRNA delivery.
Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Dendrimers; Female; Folic Acid; Gene Transfer Techniques; Head and Neck Neoplasms; Humans; Mice; Mice, Nude; Neoplasm Proteins; Neovascularization, Pathologic; Polyamines; RNA, Small Interfering; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2017 |
The Protective Roles of Folic Acid in Preventing Diabetic Retinopathy Are Potentially Associated with Suppressions on Angiogenesis, Inflammation, and Oxidative Stress.
Topics: Analysis of Variance; Animals; Biomarkers; Diabetic Retinopathy; Disease Models, Animal; Female; Folic Acid; Glycated Hemoglobin; Inflammation; Insulin; Interleukin-1beta; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Oxidative Stress; Retina; Vascular Endothelial Growth Factor A | 2019 |
cRGD-functionalized nanoparticles for combination therapy of anti-endothelium dependent vessels and anti-vasculogenic mimicry to inhibit the proliferation of ovarian cancer.
Topics: Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Chick Embryo; Endothelium, Vascular; Female; Folic Acid; Heparin; Human Umbilical Vein Endothelial Cells; Humans; Mice; Mice, Nude; Nanoparticles; Neovascularization, Pathologic; Oligopeptides; Ovarian Neoplasms; Xenograft Model Antitumor Assays | 2019 |
Transcriptomic responses provide a new mechanistic basis for the chemopreventive effects of folic acid and tributyrin in rat liver carcinogenesis.
Topics: Animals; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Carcinogenesis; Carcinoma, Hepatocellular; Diethylnitrosamine; Folic Acid; Gene Expression Regulation, Neoplastic; Glutathione S-Transferase pi; Humans; Liver Neoplasms; Male; Neoplasm Proteins; Neovascularization, Pathologic; Rats; Transcriptome; Triglycerides | 2014 |
Valproic acid substantially downregulated genes folr1, IGF2R, RGS2, COL6A3, EDNRB, KLF6, and pax-3, N-acetylcysteine alleviated most of the induced gene alterations in chicken embryo model.
Topics: Acetylcysteine; Animals; Avian Proteins; Chick Embryo; Chromatography, High Pressure Liquid; Collagen Type VI; Dose-Response Relationship, Drug; Down-Regulation; Folate Receptor 1; Folic Acid; Gene Expression Regulation, Developmental; Histone Deacetylases; Kruppel-Like Transcription Factors; Models, Biological; Neovascularization, Pathologic; Neural Tube Defects; Oligonucleotide Array Sequence Analysis; Paired Box Transcription Factors; Receptor, IGF Type 2; Receptors, Endothelin; RGS Proteins; Valproic Acid | 2013 |
Evaluation of antitumor effect of zoledronic acid entrapped in folate-linked liposome for targeting to tumor-associated macrophages.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Diphosphonates; Female; Folic Acid; Humans; Imidazoles; KB Cells; Liposomes; Macrophages; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Neovascularization, Pathologic; Tumor Cells, Cultured; Zoledronic Acid | 2015 |
Folic acid tagged nanoceria as a novel therapeutic agent in ovarian cancer.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cerium; Cisplatin; Female; Folate Receptor 1; Folic Acid; Gene Expression Regulation, Neoplastic; Humans; Mice; Nanoparticles; Neovascularization, Pathologic; Ovarian Neoplasms; Xenograft Model Antitumor Assays | 2016 |
Folate-Hapten-Mediated Immunotherapy Synergizes with Vascular Endothelial Growth Factor Receptor Inhibitors in Treating Murine Models of Cancer.
Topics: Animals; Antineoplastic Agents; Axitinib; Cell Line, Tumor; Combined Modality Therapy; Disease Models, Animal; Female; Folic Acid; Haptens; Humans; Imidazoles; Immunotherapy; Indazoles; Mice; Neoplasms; Neovascularization, Pathologic; Protein Kinase Inhibitors; Receptors, Vascular Endothelial Growth Factor; T-Lymphocyte Subsets; Tumor Burden; Xenograft Model Antitumor Assays | 2017 |
Rescue of hypercholesterolemia-related impairment of angiogenesis by oral folate supplementation.
Topics: Administration, Oral; Animals; Cholesterol; Cholesterol, HDL; Cyclic GMP; Dietary Supplements; Disease Models, Animal; Drug Evaluation, Preclinical; Folic Acid; Hindlimb; Homocysteine; Hypercholesterolemia; Ischemia; Male; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Peripheral Vascular Diseases; Rats; Rats, Sprague-Dawley; Risk Factors; Severity of Illness Index | 2003 |
Lowering homocysteine decreases levels and expression of VEGF(165) and endostatin.
Topics: Adult; Diabetes Mellitus; Down-Regulation; Endostatins; Female; Folic Acid; Gene Expression; Homocysteine; Humans; Leukocytes; Male; Middle Aged; Neovascularization, Pathologic; Peripheral Vascular Diseases; Reverse Transcriptase Polymerase Chain Reaction; Thiamine; Vascular Endothelial Growth Factor A; Vitamin B Complex | 2008 |